These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT. Dekeyne A, Rivet JM, Gobert A, Millan MJ. Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160 [Abstract] [Full Text] [Related]
8. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. Prinssen EP, Koek W, Colpaert FC, Kleven MS. Behav Pharmacol; 2000 Jun 25; 11(3-4):299-305. PubMed ID: 11103884 [Abstract] [Full Text] [Related]
16. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Vicentic A, Li Q, Battaglia G, Van de Kar LD. Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368 [Abstract] [Full Text] [Related]
19. Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors. Zahorodna A, Tokarski K, Bijak M. Eur J Pharmacol; 2002 May 17; 443(1-3):51-7. PubMed ID: 12044792 [Abstract] [Full Text] [Related]